drugset / Trial / NCT06681194

Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue

NCT06681194

Phase 2/3 Not yet recruiting 270 enrolled Francesco Egro
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled trial aims to compare the efficacy of silver nitrate, triamcinolone, and a successive use of both treatments in managing hypergranulation tissue in traumatic wounds. Conducted over a four-year period at UPMC Mercy, the study will involve patients presenting with hypergranulation tissue. Participants will be randomly assigned to receive either topical silver nitrate, topical triamcinolone, or a combination of the two in succession. The study will assess treatment outcomes based on the reduction or resolution of hypergranulation tissue, with the goal of identifying the most effective therapeutic approach. This research will provide valuable insights into optimizing treatment strategies for hypergranulation tissue in traumatic wounds.

Timeline

Start
2025-06-01
Primary completion
2028-12-31
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Silver Nitrate Other / unclassified 0.5 % Topical
Comparator Triamcinolone Other / unclassified 0.5 % Topical

Indications

No indication recorded.